Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026

Same author

Individualised N-terminal Pro-B-type Natriuretic Peptide Thresholds for the Diagnosis of Heart Failure: A Proof-of-Concept Study.

Cureus·2026

Same author

Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

bioRxiv : the preprint server for biology·2026

Same author

Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carers.

Cardio-oncology (London, England)·2026

Same author

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Nature cancer·2026

Same author

NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis.

JCI insight·2026

Same journal

MetaboNet-Bench: A Multi-modal Benchmark for Glucose Forecasting in Type 1 Diabetes.

ArXiv·2026

Same journal

A Positron Range Correction with Texture Preservation Framework in PET Imaging.

ArXiv·2026

Same journal

Automated optimization of force field parameters against ensemble-averaged measurements with Bayesian Inference of Conformational Populations.

ArXiv·2026

Same journal

Droplet Fusion as a Relaxation Process: Comparison with Shape Recovery of Newtonian and Viscoelastic Droplets.

ArXiv·2026

Same journal

Ridge-filter crosstalk in conformal proton FLASH planning: dependence on beamlet pitch and iterative mitigation.

ArXiv·2026

Same journal

Electrochemical DNA Hairpin Sensors for Differentiating Small Molecule Intercalation from Minor Groove Binding.

ArXiv·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 22, 2025

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection.

Huiming Xia^1,2, My Hoang¹, Evelyn Schmidt¹

¹Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

|July 1, 2024

Summary

This summary is machine-generated.

pVACview is a new interactive tool that helps researchers select cancer neoantigens for personalized therapies. It simplifies complex data, improving efficiency and accuracy in identifying promising neoantigen candidates for clinical applications.

Keywords:

Cancer Immunotherapy Neoantigen Pipeline Prioritization Vaccine design Visualization

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Related Experiment Videos

Last Updated: Jun 22, 2025

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Area of Science:

Oncology
Immunotherapy
Bioinformatics

Background:

Neoantigen targeting therapies, including personalized cancer vaccines, show promise, especially with checkpoint blockade therapy.
Accurate neoantigen identification and prioritization are crucial for trial design, response prediction, and understanding resistance.
Computational neoantigen prediction faces challenges due to complex factors like alternative transcripts and diverse prediction algorithms.

Purpose of the Study:

To introduce pVACview, the first interactive tool for prioritizing and selecting neoantigen candidates for personalized cancer therapies and vaccines.
To provide a user-friendly interface for uploading, exploring, selecting, and exporting neoantigen candidates.
To enable visualization of neoantigen candidates at variant, transcript, and peptide levels.

Main Methods:

Development of pVACview, an interactive visualization tool.
Integration of variant, transcript, and peptide information for neoantigen analysis.
User-friendly interface for data exploration and candidate selection.

Main Results:

pVACview offers an intuitive interface for managing neoantigen candidates.
The tool visualizes candidates across multiple data levels (variant, transcript, peptide).
Facilitates efficient and accurate analysis and prioritization of neoantigen candidates.

Conclusions:

pVACview enhances the efficiency and accuracy of neoantigen candidate analysis for researchers in basic and translational settings.
The tool supports the development of personalized neoantigen therapies and cancer vaccines.
pVACview is available via the pVACtools pipeline and as an online server.